These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


719 related items for PubMed ID: 25636084

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J, Min KL, Kang S, Yang S, Park MS, Wi J, Chang MJ.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0063321. PubMed ID: 34937189
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of meropenem in children with sepsis undergoing extracorporeal life support: A prospective observational study.
    Wang Y, Li Z, Chen W, Yan G, Wang G, Lu G, Chen C.
    J Clin Pharm Ther; 2021 Jun 22; 46(3):754-761. PubMed ID: 33476064
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V, Abdul-Aziz MH, Burrows F, Buscher H, Corley A, Diehl A, Jakob SM, Levkovich BJ, Pellegrino V, Que YA, Reynolds C, Rudham S, Wallis SC, Welch SA, Zacharias D, Roberts JA, Shekar K, Fraser JF.
    Int J Antimicrob Agents; 2021 Dec 22; 58(6):106466. PubMed ID: 34688834
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study).
    Cheng V, Abdul-Aziz MH, Burrows F, Buscher H, Cho YJ, Corley A, Gilder E, Kim HS, Lim SY, McGuinness S, Parke R, Reynolds C, Rudham S, Wallis SC, Welch SA, Fraser JF, Shekar K, Roberts JA, ASAP ECMO Investigators.
    Clin Pharmacokinet; 2022 Jun 22; 61(6):847-856. PubMed ID: 35253107
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study.
    Novy E, Abdul-Aziz MH, Cheng V, Burrows F, Buscher H, Corley A, Diehl A, Gilder E, Levkovich BJ, McGuinness S, Ordonez J, Parke R, Parker S, Pellegrino V, Reynolds C, Rudham S, Wallis SC, Welch SA, Fraser JF, Shekar K, Roberts JA.
    Antimicrob Agents Chemother; 2024 Jan 10; 68(1):e0120123. PubMed ID: 38063399
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA, Mat-Nor MB, Mohamad-Nor FS, Udy AA, Wallis SC, Lipman J, Roberts JA.
    Int J Antimicrob Agents; 2015 Jan 10; 45(1):41-5. PubMed ID: 25455853
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?
    Alobaid AS, Brinkmann A, Frey OR, Roehr AC, Luque S, Grau S, Wong G, Abdul-Aziz MH, Roberts MS, Lipman J, Roberts JA.
    J Antimicrob Chemother; 2016 Mar 10; 71(3):696-702. PubMed ID: 26702922
    [Abstract] [Full Text] [Related]

  • 20. Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
    Cheng V, Abdul-Aziz MH, Burrows F, Buscher H, Cho YJ, Corley A, Diehl A, Gilder E, Jakob SM, Kim HS, Levkovich BJ, Lim SY, McGuinness S, Parke R, Pellegrino V, Que YA, Reynolds C, Rudham S, Wallis SC, Welch SA, Zacharias D, Fraser JF, Shekar K, Roberts JA, ASAP ECMO Investigators.
    Antimicrob Agents Chemother; 2022 Jan 18; 66(1):e0137721. PubMed ID: 34633852
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.